Liang Zhu
6PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 30, 2025
WEE1 inhibitor exerts synergistic effect with KRAS G12C inhibitor via MYBL2-RRM2 axis in KRASG12C-mutant lung cancer.Chao Zhou, Yuqing Liu, Hongyu Liu
|May 02, 2025
Anlotinib enhances the efficacy of KRAS-G12C inhibitors through c-Myc/ORC2 axis inhibition in non-small cell lung cancer.Hongyu Liu, Chao Zhou, Jun Lu
|Mar 18, 2025
Therapeutic targeting de novo purine biosynthesis driven by β-catenin-dependent PPAT upregulation in hepatoblastoma.Ming Ding, Chunshuang Ma, Yanyan Lin
|Oct 04, 2022
Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma.Ming-Yu Luo, Ye Zhou, Wei-Ming Gu
|Oct 06, 2021
Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR-targeted therapy in lung cancer.Ke-Ren Zhang, Yu-Fei Zhang, Hui-Min Lei
Pageof 1
Frequent Collaborators
3 joint publications
Ying Shen
3 joint publications
Baohui Han
3 joint publications
Jun Lu
2 joint publications
Hongzhuan Chen
1 joint publications
Ke-Ren Zhang
1 joint publications
Yu-Fei Zhang
1 joint publications
Hui-Min Lei
1 joint publications
Ya-Bin Tang
1 joint publications
Hua Zhong
1 joint publications
Ming-Yu Luo